BGLC vs EIX · rev $9.5M vs P/E 7.3, rev $17.60B
BioNexus Gene Lab Corp Common stock (BGLC) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BGLC currently screens at market cap $6.1M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BGLC and EIX stock pages for the full models.
Not investment advice.